How to Use a 3-Week Opioid Use Threshold on Buprenorphine
How can clinicians use opioid use during the first 3 weeks of buprenorphine treatment to more specifically identify patients at higher risk for sustained opioid use?
By week 3, clinicians often need to decide whether continued opioid use reflects transient early difficulty or a pattern that justifies more intensive intervention. This guide applies to buprenorphine-treated patients with opioid use disorder when clinicians want a more specific threshold for escalating care.
-
Count opioid use days across the first 21 days
Review the total number of days of illicit opioid use reported during weeks 1 to 3. The study evaluated opioid use frequency over this 21-day period as an early treatment response marker.
-
Classify 2 or more days as early nonresponse
Use 2 or more days of opioid use during the first 3 weeks as the threshold for early nonresponse. In this analysis, the optimal cutoff for weeks 1 to 3 was 2 or more days of use out of 21 days.
-
Use this threshold when you need greater specificity
Apply this cutoff when deciding whether a patient may need more targeted or resource-intensive intervention. The weeks 1 to 3 threshold had specificity 0.810 and sensitivity 0.649, making it more precise than the 2-week threshold for identifying a smaller subset truly at risk.
-
Interpret 0 to 1 days of use differently
Patients with 1 or no days of opioid use in the first 3 weeks were in the lower-risk group by this threshold. Descriptively, 61% of those with 2 or more days of use later reported sustained opioid use, compared with 17% of those with 1 or no days.
-
Escalate care when the threshold is met
Treat early nonresponse by this definition as clinically meaningful because it was associated with 7.54 times greater odds of sustained opioid use during weeks 5 to 12. It was also associated with about 3.70 fewer opioid-free weeks and 1.46 fewer weeks retained in treatment, and the authors suggest this threshold may be useful for informing more intensive or costly responses such as behavioral interventions.
-
Avoid overcalling a single isolated use day
Do not automatically treat exactly 1 day of opioid use in the first 3 weeks as high risk by this 3-week definition. In exploratory analyses, outcomes did not differ significantly based on whether that single day occurred in weeks 1 to 2 or in week 3, and many patients with 1 day of use in weeks 1 to 2 did not go on to use in week 3.
Clinical Considerations
- This 3-week threshold was only marginally better at prediction than the 2-week threshold, so the choice between them depends on whether the clinical priority is sensitivity or specificity.
- The threshold had stronger negative predictive value than positive predictive value, so crossing it raises risk but does not mean poor outcome is certain.
- The study examined outcomes during weeks 5 to 12, and further research is needed to know how well this threshold predicts longer-term outcomes.
- Generalizability to naturalistic practice settings remains uncertain because the thresholds were derived from harmonized randomized trial data.
Bottom Line
Two or more opioid-use days in the first 3 weeks of buprenorphine treatment is a more specific marker of higher short-term risk and can help justify more intensive intervention.
